Viking Therapeutics: The Market Might Shrug Off The Maintenance Data (NASDAQ:VKTX)
Viking Therapeutics is advancing VK2735 for obesity and diabetes, with key maintenance study data expected in Q3 '26. Learn why VKTX stock is a hold.
We can't find the internet
Attempting to reconnectSomething went wrong!
Attempting to reconnectViking Therapeutics is advancing VK2735 for obesity and diabetes, with key maintenance study data expected in Q3 '26. Learn why VKTX stock is a hold.
Today reads warmer than 2 of the last 6 scored days. Click a bar to read that day's stories.